Fact CheckerSign in

NCT07128927Recruiting

Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors

Source: ClinicalTrials.gov · Last updated 26 Oct 2026

Brief summary (registry, in English)

This pilot study will recruit Black/African American prostate cancer survivors into a clinical trial and will randomize each person to 1 of 2 possible treatments - an internet-based treatment for insomnia called Sleep Healthy Using the Internet (SHUTi) or an educational website. SHUTi provides the treatment - cognitive behavioral therapy for insomnia - across 6 lessons, while the educational website is like an online patient brochure. The study will examine the feasibility of SHUTi to improve sleep and well-being among Black prostate cancer survivors. It will also examine whether SHUTi is acceptable to these survivors and will compare the effect of SHUTi versus the educational website on insomnia and non-insomnia patient-reported outcomes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
5 Aug 2025
Start date
1 Dec 2025
Primary completion date
1 Sept 2027
Lead sponsor
Georgetown University
NCT number
NCT07128927

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Dec 2025 to the primary completion date, 1 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosed with a severe/major psychiatric disorder
  • Diagnosed with a seizure disorder or recently (≤12 months) experienced a seizure

Other

  • Employed in an occupation where sleep restriction could be a harm to themselves or others
  • Actively employed in shift work
  • Unable to consent

Who the study is looking for

  • Age ≥21 years
  • Self-identifies as Black/African American
  • Diagnosed with invasive prostate cancer (AJCC stages I-IV) within 5 years
  • Has not received surgery, chemotherapy, or radiation within the previous 3 months
  • Has a smart phone, tablet, or computer with reliable internet access or willing to attend a weekly study appointment and to complete a weekly phone call
  • Has clinically relevant insomnia symptoms (i.e., score ≥10 on the Insomnia Severity Index)
  • Able to read and understand English

Age in the registry: 21 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Georgetown Lombardi Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Washington D.C.United StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.